尼膜同治疗急性脑出血的前瞻性研究-东南大学学报医学版

尼膜同治疗急性脑出血的前瞻性研究

单位：南京铁道医学院附属扬州医院,神经内科,江苏,扬州,225001

分类号：R743.34, R972

出版年·卷·期（页码）：2000·19·第一期（45-47）

摘要：

目的:将实验性脑出血的缺血性损害理论用于临床,观察尼膜同静脉输注治疗急性脑出血的临床疗效.方法:应用前瞻性随机单盲方法,对182例经CT证实的急性脑出血病人,在起病72-h内随机接受尼膜同或单纯甘露醇治疗,以神经功能缺损程度积分差及CT上血肿吸收率为指标,比较两组疗效.结果:尼膜同组在各个时点上神经功能缺损的平均减少分数以及CT上血肿吸收率均优于常规治疗组.结论:尼膜同是治疗急性脑出血的一种安全、有效的新方法.

Objective The purpose of the study was to applying the mechanisms of ischemic brain after experimental intracerebral hemorrhage.Methods With the prospective random single blind method, 182 cases of acute intracerebral hemorrhage patients who are confirmed by CT scan randomly accepted the treatment of nimotop or pure mannitol within 72 hours after onset of hemorrhage.The two groups are compared with the indexes of the score difference of neurologic defects and the hematomas absorptive rate.Result The average decreased scores of neurologic defects with treatment of nimotop at each time point and the hematoma absorptive rate are better than that in the routine treatment group.Conclusion Nimotop is a safe and effective new method in treatment of acute intracerebral hemorrhage.

参考文献：

[1] Cechetto DF. Mechanisms of ischemic brain damage with intracerebral hemorrhage, 1993
[2] 郭富强. 实验性脑出血的缺血性损害及其防治的研究进展, 1998
[3] Hubschmann O R, Nathanson O C. The role of calcium and cellular membrane dysfunction in experimental trauma and subarachnoid hemorrhage. 1985. doi:10.3171/jns.1985.62.5.0698
[4] 刘士民. 脑水肿的研究进展, 1997
[5] 易声禹, 费丹, 徐如祥. 尼莫地平救治重型颅脑损伤的理论基础与临床研究, 1994
[6] 刘士民. 尼莫地平在中枢神经系统疾患中应用的药理学基础, 1997
[7] Hadley M N, Spetzler R F, Fifield M S. The effect of nimodipine on intracranial pressure.Volume-pressme studies in a primate model, 1987
[8] Peteson DL, Tanaka R, Takeuch S. Hematoma enlargement in spontaneous intracerebral hemorrhage, 1994
[9] Bae H G, Lee K S, Yun I G. Hematoma enlargement, 1992
[10] Sinar E J, Mendelow A D, Graham D I. Experimental intracerebral hemorrhage:the effect of nimodipine pretreatment, 1998

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录